245 related articles for article (PubMed ID: 32094505)
1. Epitopes for a 2019-nCoV vaccine.
Lucchese G
Cell Mol Immunol; 2020 May; 17(5):539-540. PubMed ID: 32094505
[No Abstract] [Full Text] [Related]
2. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine.
Kanduc D; Shoenfeld Y
Immunol Res; 2020 Oct; 68(5):310-313. PubMed ID: 32946016
[No Abstract] [Full Text] [Related]
3. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach.
Bhattacharya M; Sharma AR; Patra P; Ghosh P; Sharma G; Patra BC; Lee SS; Chakraborty C
J Med Virol; 2020 Jun; 92(6):618-631. PubMed ID: 32108359
[TBL] [Abstract][Full Text] [Related]
4. Immunoinformatics-guided design of an epitope-based vaccine against severe acute respiratory syndrome coronavirus 2 spike glycoprotein.
Rakib A; Sami SA; Mimi NJ; Chowdhury MM; Eva TA; Nainu F; Paul A; Shahriar A; Tareq AM; Emon NU; Chakraborty S; Shil S; Mily SJ; Ben Hadda T; Almalki FA; Emran TB
Comput Biol Med; 2020 Sep; 124():103967. PubMed ID: 32828069
[TBL] [Abstract][Full Text] [Related]
5. The biological characteristics of SARS-CoV-2 spike protein Pro330-Leu650.
Su QD; Yi Y; Zou YN; Jia ZY; Qiu F; Wang F; Yin WJ; Zhou WT; Zhang S; Yu PC; Bi SL; Shen LP; Wu GZ
Vaccine; 2020 Jul; 38(32):5071-5075. PubMed ID: 32513514
[TBL] [Abstract][Full Text] [Related]
6. Design of a multi-epitope vaccine against SARS-CoV-2 using immunoinformatics approach.
Sanami S; Zandi M; Pourhossein B; Mobini GR; Safaei M; Abed A; Arvejeh PM; Chermahini FA; Alizadeh M
Int J Biol Macromol; 2020 Dec; 164():871-883. PubMed ID: 32682041
[TBL] [Abstract][Full Text] [Related]
7. Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering the coronavirus glycan-shield to present α-gal epitopes.
Galili U
Vaccine; 2020 Sep; 38(42):6487-6499. PubMed ID: 32907757
[TBL] [Abstract][Full Text] [Related]
8. Approaches and Challenges in SARS-CoV-2 Vaccine Development.
Dagotto G; Yu J; Barouch DH
Cell Host Microbe; 2020 Sep; 28(3):364-370. PubMed ID: 32798444
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E
J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510
[TBL] [Abstract][Full Text] [Related]
10. Status of COVID-19 vaccine development.
Taxt AM; Grødeland G; Lind A; Müller F
Tidsskr Nor Laegeforen; 2020 Sep; 140(13):. PubMed ID: 32998488
[TBL] [Abstract][Full Text] [Related]
11. Impact of glycoscience in fighting Covid-19.
Adamo R; Sonnino S
Glycoconj J; 2020 Aug; 37(4):511-512. PubMed ID: 32504168
[No Abstract] [Full Text] [Related]
12. A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2.
Tai W; Zhang X; Drelich A; Shi J; Hsu JC; Luchsinger L; Hillyer CD; Tseng CK; Jiang S; Du L
Cell Res; 2020 Oct; 30(10):932-935. PubMed ID: 32759966
[No Abstract] [Full Text] [Related]
13. COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance.
Robson B
Comput Biol Med; 2020 Jun; 121():103749. PubMed ID: 32568687
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Folegatti PM; Ewer KJ; Aley PK; Angus B; Becker S; Belij-Rammerstorfer S; Bellamy D; Bibi S; Bittaye M; Clutterbuck EA; Dold C; Faust SN; Finn A; Flaxman AL; Hallis B; Heath P; Jenkin D; Lazarus R; Makinson R; Minassian AM; Pollock KM; Ramasamy M; Robinson H; Snape M; Tarrant R; Voysey M; Green C; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ;
Lancet; 2020 Aug; 396(10249):467-478. PubMed ID: 32702298
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2: A New Song Recalls an Old Melody.
Subbarao K
Cell Host Microbe; 2020 May; 27(5):692-694. PubMed ID: 32407706
[TBL] [Abstract][Full Text] [Related]
16. Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2.
Tahir Ul Qamar M; Shahid F; Aslam S; Ashfaq UA; Aslam S; Fatima I; Fareed MM; Zohaib A; Chen LL
Infect Dis Poverty; 2020 Sep; 9(1):132. PubMed ID: 32938504
[TBL] [Abstract][Full Text] [Related]
17. Fast-and-fit vaccines.
Nat Biomed Eng; 2020 Aug; 4(8):757-758. PubMed ID: 32760006
[No Abstract] [Full Text] [Related]
18. Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2.
Kalita P; Padhi AK; Zhang KYJ; Tripathi T
Microb Pathog; 2020 Aug; 145():104236. PubMed ID: 32376359
[TBL] [Abstract][Full Text] [Related]
19. mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.
Yi C; Yi Y; Li J
Virol Sin; 2020 Jun; 35(3):259-262. PubMed ID: 32524253
[No Abstract] [Full Text] [Related]
20. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
